Published :
Tables : 57
Figures : 51
Category : Healthcare
No. of Pages : 245
Report Code : HC-U9071
Gastroesophageal Reflux Disease Devices Market is poised to value over CAGR of over 13.5% during the forecast period 2022 to 2028. GERD is a disorder in which the lower esophageal sphincter (LES) relaxes or fails to function properly, allowing stomach liquids to reflux back into the oesophagus and cause heartburn. GERD is caused by a number of causes including smoking, hiatal hernia, abdominal obesity, and stress. GERD can cause esophagitis (swelling of the oesophagus), Barrett's oesophagus (barrel disease), and ulcers if left untreated. The severity of the condition is used to create treatment modules. In many countries, increased rates of abdominal obesity, as well as unhealthy diets and lifestyles, are linked to an increase in the prevalence of GERD. The demand for gastroesophageal reflux disease devices will rise as a result of this. The prevalence of gastroesophageal reflux is not gender-specific; nevertheless, males are more likely to develop problems as a result of the disease. GERD is more common as people get older, especially after the age of 40. The difficulties related with esophageal motility and a decreased production of saliva are linked to esophageal dysfunction in the older population. As a result, the growing senior population will continue to drive the market for gastroesophageal reflux disease devices. One of the primary factors driving market expansion is the high rate of obesity in the United States. FutureWise Market Research has instantiated a report that provides an intricate analysis of Gastroesophageal Reflux Disease Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Gastroesophageal Reflux Disease Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Gastroesophageal Reflux Disease Devices Market: • Addex Pharmaceuticals Ltd. • Aros Pharma ApS • AstraZeneca Plc. • C. R. Bard, Inc. • Eisai Co., Ltd. • EndoGastric Solutions, Inc. • KARL STORZ SE & Co. KG. • MediGus Ltd. • Olympus Corporation • PENTAX Medical (Global) • Pfizer Inc. • Takeda Pharmaceutical Company Limited • The Procter & Gamble Company (Note: The list of the major players will be updated with the latest market scenario and trends) Gastroesophageal Reflux Disease Devices Market Segmentation: By Product Type • Diagnostic Devices • Esophagoscopes and Gastroscopes • Fundoplication Devices • Manometry System • PH Monitoring System • Radiofrequency Ablation Devices • Sphincter Augmentation Devices • Treatment Devices • Ultrasonic Surgical Endostapler By Procedure Type • Diagnostic Procedures • Fundoplication Procedures • Magnetic Sphincter Augmentation • Radiofrequency Thermal Ablation By Device Type • Bravo Reflux Testing System • Digitrapper reflux testing system • LINX Management System • MUSE -Medigus Ultrasonic Surgical Endostapler • Others • Stretta Therapy By Surgery Type • Invasive o Linx Reflux Management o Medigus Ultrasonic Surgical Endostapler • Non-invasive o Endocinch Endolumminal gastroplication o Endoscopic Plicator System o EsophyX o Plexiglas poly-methyl-methacrylate (PMMA) microspheres o Stretta By Route of Administration • Oral • Parenteral By Dosage Form • Liquid • Solid By End Users • Government • Hospitals • Medical Practitioners • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Gastroesophageal Reflux Disease Devices Market By Product Type, By Procedure Type, By Device Type, By Surgery Type, By Route of Administration, By Dosage Form, By End Users and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
GERD is a disorder in which the lower esophageal sphincter (LES) relaxes or fails to function properly, allowing stomach liquids to reflux back into the oesophagus and cause heartburn. GERD is caused by a number of causes including smoking, hiatal hernia, abdominal obesity, and stress. GERD can cause esophagitis (swelling of the oesophagus), Barrett's oesophagus (barrel disease), and ulcers if left untreated. The severity of the condition is used to create treatment modules. In many countries, increased rates of abdominal obesity, as well as unhealthy diets and lifestyles, are linked to an increase in the prevalence of GERD. The demand for gastroesophageal reflux disease devices will rise as a result of this. The prevalence of gastroesophageal reflux is not gender-specific; nevertheless, males are more likely to develop problems as a result of the disease. GERD is more common as people get older, especially after the age of 40. The difficulties related with esophageal motility and a decreased production of saliva are linked to esophageal dysfunction in the older population. As a result, the growing senior population will continue to drive the market for gastroesophageal reflux disease devices. One of the primary factors driving market expansion is the high rate of obesity in the United States.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Gastroesophageal Reflux Disease Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Gastroesophageal Reflux Disease Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Gastroesophageal Reflux Disease Devices Market: • Addex Pharmaceuticals Ltd. • Aros Pharma ApS • AstraZeneca Plc. • C. R. Bard, Inc. • Eisai Co., Ltd. • EndoGastric Solutions, Inc. • KARL STORZ SE & Co. KG. • MediGus Ltd. • Olympus Corporation • PENTAX Medical (Global) • Pfizer Inc. • Takeda Pharmaceutical Company Limited • The Procter & Gamble Company (Note: The list of the major players will be updated with the latest market scenario and trends)
Gastroesophageal Reflux Disease Devices Market Segmentation: By Product Type • Diagnostic Devices • Esophagoscopes and Gastroscopes • Fundoplication Devices • Manometry System • PH Monitoring System • Radiofrequency Ablation Devices • Sphincter Augmentation Devices • Treatment Devices • Ultrasonic Surgical Endostapler By Procedure Type • Diagnostic Procedures • Fundoplication Procedures • Magnetic Sphincter Augmentation • Radiofrequency Thermal Ablation By Device Type • Bravo Reflux Testing System • Digitrapper reflux testing system • LINX Management System • MUSE -Medigus Ultrasonic Surgical Endostapler • Others • Stretta Therapy By Surgery Type • Invasive o Linx Reflux Management o Medigus Ultrasonic Surgical Endostapler • Non-invasive o Endocinch Endolumminal gastroplication o Endoscopic Plicator System o EsophyX o Plexiglas poly-methyl-methacrylate (PMMA) microspheres o Stretta By Route of Administration • Oral • Parenteral By Dosage Form • Liquid • Solid By End Users • Government • Hospitals • Medical Practitioners • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Gastroesophageal Reflux Disease Devices Market By Product Type, By Procedure Type, By Device Type, By Surgery Type, By Route of Administration, By Dosage Form, By End Users and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Gastroesophageal Reflux Disease Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Gastroesophageal Reflux Disease Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Gastroesophageal Reflux Disease Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Gastroesophageal Reflux Disease Devices Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Diagnostic Devices 7.2. Esophagoscopes and Gastroscopes 7.3. Fundoplication Devices 7.4. Manometry System 7.5. PH Monitoring System 7.6. Radiofrequency Ablation Devices 7.7. Sphincter Augmentation Devices 7.8. Treatment Devices 7.9. Ultrasonic Surgical Endostapler 8. Gastroesophageal Reflux Disease Devices Market, By Procedure Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Diagnostic Procedures 8.2. Fundoplication Procedures 8.3. Magnetic Sphincter Augmentation 8.4. Radiofrequency Thermal Ablation 9. Gastroesophageal Reflux Disease Devices Market, By Device Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Bravo Reflux Testing System 9.2. Digitrapper reflux testing system 9.3. LINX Management System 9.4. MUSE -Medigus Ultrasonic Surgical Endostapler 9.5. Others 9.6. Stretta Therapy 10. Gastroesophageal Reflux Disease Devices Market, By Surgery Type Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Invasive 10.1.1. Linx Reflux Management 10.1.2. Medigus Ultrasonic Surgical Endostapler 10.2. Non-invasive 10.2.1. Endocinch Endolumminal gastroplication 10.2.2. Endoscopic Plicator System 10.2.3. EsophyX 10.2.4. Plexiglas poly-methyl-methacrylate (PMMA) microspheres 10.2.5. Stretta 11. Gastroesophageal Reflux Disease Devices Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Oral 11.2. Parenteral 12. Gastroesophageal Reflux Disease Devices Market, By Dosage Form Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Liquid 12.2. Solid 13. Gastroesophageal Reflux Disease Devices Market, By End Users Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Government 13.2. Hospitals 13.3. Medical Practitioners 13.4. Others 14. North America Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. U.S.A 14.2.2. Canada 14.2.3. Mexico 14.3. Market Size (USD Million) Forecast for North America 2022-2028 15. Latin America Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Brazil 15.2.2. Venezuela 15.2.3. Argentina 15.2.4. Rest of Latin America 15.3. Market Size (USD Million) Forecast for Latin America 2022-2028 16. Europe Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Germany 16.2.2. U.K 16.2.3. France 16.2.4. Italy 16.2.5. Spain 16.2.6. Russia 16.2.7. Poland 16.2.8. Rest of Europe 16.3. Market Size (USD Million) Forecast for Europe 2022-2028 17. Asia Pacific Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. Japan 17.2.2. China 17.2.3. India 17.2.4. Australia and New Zealand 17.2.5. ASEAN 17.2.6. Rest of Asia Pacific 17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 18. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 18.2.1. GCC 18.2.2. Israel 18.2.3. South Africa 18.2.4. Rest of MEA 18.3. Market Size (USD Million) Forecast for MEA 2022-2028 19. Market Share Analysis and Competitive Landscape 19.1. Global Landscape - Key Players, Revenue and Presence 19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 19.3. Global Emerging Companies 19.4. North America - Market Share Analysis and Key Regional Players 19.5. Europe - Market Share Analysis and Key Regional Players 19.6. Asia Pacific - Market Share Analysis and Key Regional Players 19.7. Global Key Player - Growth Matrix 20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 20.1. Addex Pharmaceuticals Ltd. 20.1.1. Company Overview 20.1.2. Product Portfolio 20.1.3. SWOT Analysis 20.1.4. Financial Overview 20.1.5. Strategic Overview 20.2. Aros Pharma ApS 20.2.1. Company Overview 20.2.2. Product Portfolio 20.2.3. SWOT Analysis 20.2.4. Financial Overview 20.2.5. Strategic Overview 20.3. AstraZeneca Plc. 20.3.1. Company Overview 20.3.2. Product Portfolio 20.3.3. SWOT Analysis 20.3.4. Financial Overview 20.3.5. Strategic Overview 20.4. C. R. Bard, Inc. 20.4.1. Company Overview 20.4.2. Product Portfolio 20.4.3. SWOT Analysis 20.4.4. Financial Overview 20.4.5. Strategic Overview 20.5. Eisai Co., Ltd. 20.5.1. Company Overview 20.5.2. Product Portfolio 20.5.3. SWOT Analysis 20.5.4. Financial Overview 20.5.5. Strategic Overview 20.6. EndoGastric Solutions, Inc. 20.6.1. Company Overview 20.6.2. Product Portfolio 20.6.3. SWOT Analysis 20.6.4. Financial Overview 20.6.5. Strategic Overview 20.7. KARL STORZ SE & Co. KG. 20.7.1. Company Overview 20.7.2. Product Portfolio 20.7.3. SWOT Analysis 20.7.4. Financial Overview 20.7.5. Strategic Overview 20.8. MediGus Ltd. 20.8.1. Company Overview 20.8.2. Product Portfolio 20.8.3. SWOT Analysis 20.8.4. Financial Overview 20.8.5. Strategic Overview 20.9. Olympus Corporation 20.9.1. Company Overview 20.9.2. Product Portfolio 20.9.3. SWOT Analysis 20.9.4. Financial Overview 20.9.5. Strategic Overview 20.10.PENTAX Medical (Global) 20.10.1. Company Overview 20.10.2. Product Portfolio 20.10.3. SWOT Analysis 20.10.4. Financial Overview 20.10.5. Strategic Overview 20.11.Pfizer Inc. 20.11.1. Company Overview 20.11.2. Product Portfolio 20.11.3. SWOT Analysis 20.11.4. Financial Overview 20.11.5. Strategic Overview 20.12.Takeda Pharmaceutical Company Limited 20.12.1. Company Overview 20.12.2. Product Portfolio 20.12.3. SWOT Analysis 20.12.4. Financial Overview 20.12.5. Strategic Overview 20.13.The Procter & Gamble Company 20.13.1. Company Overview 20.13.2. Product Portfolio 20.13.3. SWOT Analysis 20.13.4. Financial Overview 20.13.5. Strategic Overview 21. Pre and Post COVID-19 Impact 21.1. Positive influence on the healthcare industry 21.2. The financial disruption of the manufacturing sector 21.3. Impact of COVID-19 on emerging companies 21.4. Significant mandates in the healthcare regulations initiated by administrations 21.5. The overall economic slowdown of the developing and developed nations 22. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics